Vivo Grande is Vivo Now's physician-prescribed compounded tirzepatide program - a significant advancement in weight loss medicine. Where semaglutide targets one hormone, Vivo Grande targets two: GLP-1 and GIP.

How It Works

GLP-1 signals fullness and slows gastric emptying. GIP enhances insulin sensitivity, promotes more efficient fat metabolism, and increases energy utilization. Together they send stronger satiety signals, reduce food noise, and support more meaningful metabolic change.

What to Expect

The SURMOUNT-1 clinical trial showed participants lost an average of 20.9% of their body weight over 72 weeks - one of the most effective non-surgical weight loss interventions studied to date.

The Vivo Now Difference

Your protocol is prescribed and monitored by a board-certified Vivo Now physician. We start low and titrate gradually based on your response, tolerance, and progress.

Administration

Administered once weekly as a subcutaneous injection. Available as pre-filled syringes or injection pen. Compounded in an FDA-compliant certified sterile pharmacy.

Who It's For

BMI of 30 or higher (or 27+ with a weight-related health condition)
Want the most clinically advanced dual-action weight loss therapy available
Have tried semaglutide with limited results
Committed to a medically supervised long-term weight loss program

Common Side Effects

Predominantly gastrointestinal - nausea, reduced appetite, mild digestive changes - most noticeable during dose escalation. Your provider will titrate carefully to minimize discomfort.

This product requires a medical consultation and prescription. Eligibility is determined by a licensed Vivo Now provider.